Farge, D., Loisel, S., Resche-Rigon, M., Lansiaux, P., Colmegna, I., Langlais, D., Charles, C., Pugnet, G., Maria, A. T. J., Chatelus, E., Martin, T., Hachulla, E., Kheav, V. D., Lambert, N. C., Wang, H., Michonneau, D., Martinaud, C., Sensebé, L., Cras, A., & Tarte, K. (2022). safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study. Lancet, 4, e91–e104. http://access.bl.uk/ark:/81055/vdc_100150533686.0x000001